Meihua director reports option on 19 shares
Meihua International Medical Technologies Co., Ltd. director Jia Wenzhang reported an existing option position in a Form 3/A amendment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Meihua International Medical Technologies Co., Ltd. director Jia Wenzhang reported an existing option position in a Form 3/A amendment. The filing shows a stock option with an exercise price of $530.0000 per share, linked to 19.0000 shares of common stock and expiring on June 27, 2032. Following this report, the option position covers a total of 19.0000 underlying common shares held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Option | -- | -- | -- |
Key Figures
Key Terms
Option financial
Common Stock financial
Form 3/A regulatory
derivative holding financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Meihua International (MHUA) disclose in this Form 3/A?
What is the exercise price of the reported Meihua (MHUA) stock option?
When does the reported Meihua (MHUA) stock option expire?
Is this Meihua (MHUA) Form 3/A a new insider trade or a holdings update?
AI-generated analysis. How Rhea-AI works. Not financial advice.